The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Primiano Christopher Brett since year 2005.
The trader's CIK number is 1603510.
At the time of this reporting, Primiano Christopher Brett is the SVP, OPS, BUS DEV, GC & SEC of Karyopharm Therapeutics Inc. .
(stock ticker symbol KPTI).
See this page for all insider trading activities at Karyopharm Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-10-02||KPTI||Karyopharm Therapeutics Inc.||Sale||1,500||12.00||18,000|
|2017-09-15||KPTI||Karyopharm Therapeutics Inc.||Sale||2,000||11.00||22,000|
|2017-06-26||KPTI||Karyopharm Therapeutics Inc.||Sale||805||10.03||8,070|
|2017-08-29||KPTI||Karyopharm Therapeutics Inc.||Sale||2,195||10.00||21,950|
|2016-11-09||KPTI||Karyopharm Therapeutics Inc.||Sale||4,342||8.19||35,543|
|2016-11-05||KPTI||Karyopharm Therapeutics Inc.||Option Ex||15,000||.00||0|
|2014-05-13||KPTI||Karyopharm Therapeutics Inc.||Buy||1,000||26.75||26,750|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Primiano Christopher Brett (SVP, OPS, BUS DEV, GC & SEC of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.